Print Page

Products found to contain undeclared medicines

 
The United States: Latin Foods Market issues voluntary nationwide recall of Artri King Reforzado con Ortiga y Omega 3 due to the presence of undeclared diclofenac and dexamethasone
 
The US Food and Drug Administration (FDA) announces that Latin Foods Market is voluntarily recalling one lot, LOTE 334 21, of Artri King Reforzado con Ortiga y Omega 3 tablets to the consumer level. FDA analysis has found the product to be tainted with diclofenac and dexamethasone.

Diclofenac and dexamethasone are both FDA approved drugs. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and arthritis and dexamethasone is a corticosteroid indicated for a variety of indications including but not limited to arthritis. Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, in those who have allergies to diclofenac, or those with underlying illnesses. Consumption of undeclared dexamethasone may lead to severe and serious adverse events such as adrenal suppression, a disorder in which the adrenal glands do not produce enough hormones, and adverse consequences can range from limited adverse consequences to death. To date, Latin Foods Market has not received any reports of adverse events related to this recall.

Artri King Reforzado con Ortiga y Omega 3 is marketed as a dietary supplement for relief of pain and inflammation associated with arthritis and osteoarthritis.

Please refer to the following website in FDA for details: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/latin-foods-market-issues-voluntary-nationwide-recall-artri-king-reforzado-con-ortiga-y-omega-3-due

In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 22 Apr 2022.

Ends/Thursday, Jun 16, 2022
Issued at HKT 14:00
 
Related Information:
Australia: Safety advisory: Artri King Tablets contain the undeclared substances... Posted 2024-01-31
The United States: Botanical-Be issues voluntary nationwide recall of Kuka Flex ... Posted 2023-10-24
The United States: Public Notification: Artri King contains hidden drug ingredie... Posted 2022-04-22
 
back